Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 26Colorectal Neoplasms 17Colonic Neoplasms 15Central Nervous System Neoplasms 15Rectal Neoplasms 11Glioblastoma 7Lung Neoplasms 6Kidney Neoplasms 6Gliosarcoma 6Carcinoma, Non-Small-Cell Lung 6Brain Neoplasms 6Astrocytoma 6Ovarian Neoplasms 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Ovarian Epithelial 5Sarcoma 4Neoplasm Metastasis 4Melanoma 4Fallopian Tube Neoplasms 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neuroblastoma 3Glioma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2

Interventions

montanide ISA 51 3Temozolomide 3Ipilimumab 3Interleukin-2 3sargramostim 2incomplete Freund's adjuvant 2glembatumumab vedotin 2aldesleukin 2Vorinostat 2Sunitinib 2Paclitaxel 2MART-1 Antigen 2Lenalidomide 2Dacarbazine 2Cyclophosphamide 2Carboplatin 2CR011-vcMMAE 2Amplified Fragment Length Polymorphism Analysis 2trametinib 1poly ICLC 1omipalisib 1fludarabine phosphate 1fludarabine 1flt3 ligand protein 1entinostat 1cixutumumab 1cediranib 1cabozantinib 1aflibercept 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Uveal Melanoma × Chemotherapy, Adjuvant × Clear all
NCT00489944 2014-01-10

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡